Related Experiment Video
Updated: Aug 25, 2025

05:56
Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
Published on: April 3, 2016
9.0K
Retinoid-associated myopia in dermatologic patients: a systematic review
Gabriele Roccuzzo1, Tommaso Tibaldi2, Francesco Cavallo1
1Department of Medical Sciences, Section of Dermatology, University of Turin, Turin, Italy.
Cutaneous and Ocular Toxicology
|October 19, 2022
Summary
Systemic retinoids may cause myopia, but evidence is inconclusive. Further research is needed to confirm the link between retinoid use and refractive errors in dermatologic patients.
Area of Science:
- Dermatology and Ophthalmology
- Pharmacology
- Ophthalmology
Background:
- Systemic retinoids are widely used in dermatology for their keratinization normalization and proliferation modulation properties.
- Common side effects are well-documented, but ocular disturbances, particularly myopia, require further investigation due to heterogeneous findings.
- The potential correlation between retinoid use and refractive errors, specifically myopia, has not been thoroughly addressed.
Approach:
- A systematic literature review was conducted following PRISMA guidelines.
- Searches included MEDLINE, Pubmed, Scopus, and Cochrane Library using terms like retinoid, myopia, and refractive errors.
- English-language articles were considered, excluding animal and in vitro studies.
Key Points:
- Six articles were included, with varying study designs (prospective studies, case reports, retrospective analysis).
- Some studies indicated a myopic shift associated with retinoid therapy, while others showed no progression.
- One retrospective study classified myopia as a certain side effect of retinoid use.
Conclusions:
- Current literature does not establish a clear correlation between systemic retinoids and myopia development or worsening.
- While some evidence suggests a potential myopic shift, large-scale, well-controlled prospective studies are lacking.
- Ophthalmological referral is advised for ocular disturbances during retinoid therapy to rule out drug-related refractive errors.

